tiprankstipranks
Advertisement
Advertisement
Myriad Genetics to deliver six abstracts at AACR 2026
PremiumThe FlyMyriad Genetics to deliver six abstracts at AACR 2026
2M ago
Myriad Genetics announces FDA approval for MyChoice CDx Test
Premium
The Fly
Myriad Genetics announces FDA approval for MyChoice CDx Test
3M ago
S&P 600 adding fifteen companies at open on 3/23
Premium
The Fly
S&P 600 adding fifteen companies at open on 3/23
3M ago
Myriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
PremiumThe FlyMyriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
3M ago
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
Premium
Ratings
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
3M ago
Balancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
Premium
Ratings
Balancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
3M ago
Myriad announce publication of validation of FirstGene Multiple Prenatal Screen
PremiumThe FlyMyriad announce publication of validation of FirstGene Multiple Prenatal Screen
3M ago
Myriad Genetics management to meet with BTIG
Premium
The Fly
Myriad Genetics management to meet with BTIG
4M ago
Myriad Genetics advances MRD commercialization timeline
Premium
The Fly
Myriad Genetics advances MRD commercialization timeline
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100